155 related articles for article (PubMed ID: 21922472)
1. Clinical and pathological heterogeneity in late-onset partial merosin deficiency.
Rajakulendran S; Parton M; Holton JL; Hanna MG
Muscle Nerve; 2011 Oct; 44(4):590-3. PubMed ID: 21922472
[TBL] [Abstract][Full Text] [Related]
2. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency.
Tan E; Topaloglu H; Sewry C; Zorlu Y; Naom I; Erdem S; D'Alessandro M; Muntoni F; Dubowitz V
Neuromuscul Disord; 1997 Mar; 7(2):85-9. PubMed ID: 9131648
[TBL] [Abstract][Full Text] [Related]
3. Limb girdle muscular dystrophy due to
Magri F; Brusa R; Bello L; Peverelli L; Del Bo R; Govoni A; Cinnante C; Colombo I; Fortunato F; Tironi R; Corti S; Grimoldi N; Sciacco M; Bresolin N; Pegoraro E; Moggio M; Comi GP
Acta Myol; 2020 Jun; 39(2):67-82. PubMed ID: 32904964
[TBL] [Abstract][Full Text] [Related]
4. High creatine kinase levels and white matter changes: clinical and genetic spectrum of congenital muscular dystrophies with laminin alpha-2 deficiency.
Beytía Mde L; Dekomien G; Hoffjan S; Haug V; Anastasopoulos C; Kirschner J
Mol Cell Probes; 2014 Aug; 28(4):118-22. PubMed ID: 24225367
[TBL] [Abstract][Full Text] [Related]
5. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.
Jones KJ; Morgan G; Johnston H; Tobias V; Ouvrier RA; Wilkinson I; North KN
J Med Genet; 2001 Oct; 38(10):649-57. PubMed ID: 11584042
[TBL] [Abstract][Full Text] [Related]
6. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain.
Sewry CA; Naom I; D'Alessandro M; Sorokin L; Bruno S; Wilson LA; Dubowitz V; Muntoni F
Neuromuscul Disord; 1997 May; 7(3):169-75. PubMed ID: 9185180
[TBL] [Abstract][Full Text] [Related]
7. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).
Allamand V; Guicheney P
Eur J Hum Genet; 2002 Feb; 10(2):91-4. PubMed ID: 11938437
[TBL] [Abstract][Full Text] [Related]
8. Merosin-deficient congenital muscular dystrophy type 1A.
Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
[TBL] [Abstract][Full Text] [Related]
9. Merosin-deficient congenital muscular dystrophy with mental retardation and cerebellar cysts, unlinked to the LAMA2, FCMD, MEB and CMD1B loci, in three Tunisian patients.
Triki C; Louhichi N; Méziou M; Choyakh F; Kéchaou MS; Jlidi R; Mhiri C; Fakhfakh F; Ayadi H
Neuromuscul Disord; 2003 Jan; 13(1):4-12. PubMed ID: 12467726
[TBL] [Abstract][Full Text] [Related]
10. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy.
Naom I; D'Alessandro M; Sewry CA; Philpot J; Manzur AY; Dubowitz V; Muntoni F
Neuromuscul Disord; 1998 Oct; 8(7):495-501. PubMed ID: 9829280
[TBL] [Abstract][Full Text] [Related]
11. An early onset muscular dystrophy with diaphragmatic involvement, early respiratory failure and secondary alpha2 laminin deficiency unlinked to the LAMA2 locus on 6q22.
Muntoni F; Taylor J; Sewry CA; Naom I; Dubowitz V
Eur J Paediatr Neurol; 1998; 2(1):19-26. PubMed ID: 10726842
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort.
Quijano-Roy S; Haberlova J; Castiglioni C; Vissing J; Munell F; Rivier F; Stojkovic T; Malfatti E; Gómez García de la Banda M; Tasca G; Costa Comellas L; Benezit A; Amthor H; Dabaj I; Gontijo Camelo C; Laforêt P; Rendu J; Romero NB; Cavassa E; Fattori F; Beroud C; Zídková J; Leboucq N; Løkken N; Sanchez-Montañez Á; Ortega X; Kynčl M; Metay C; Gómez-Andrés D; Carlier RY
J Neurol; 2022 May; 269(5):2414-2429. PubMed ID: 34559299
[TBL] [Abstract][Full Text] [Related]
13. Limb girdle muscular dystrophy due to LAMA2 mutations: diagnostic difficulties due to associated peripheral neuropathy.
Chan SH; Foley AR; Phadke R; Mathew AA; Pitt M; Sewry C; Muntoni F
Neuromuscul Disord; 2014 Aug; 24(8):677-83. PubMed ID: 24957499
[TBL] [Abstract][Full Text] [Related]
14. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein.
Nissinen M; Helbling-Leclerc A; Zhang X; Evangelista T; Topaloglu H; Cruaud C; Weissenbach J; Fardeau M; Tomé FM; Schwartz K; Tryggvason K; Guicheney P
Am J Hum Genet; 1996 Jun; 58(6):1177-84. PubMed ID: 8651294
[TBL] [Abstract][Full Text] [Related]
15. Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study.
Bouman K; Groothuis JT; Doorduin J; van Alfen N; Udink Ten Cate FEA; van den Heuvel FMA; Nijveldt R; van Tilburg WCM; Buckens SCFM; Dittrich ATM; Draaisma JMT; Janssen MCH; Kamsteeg EJ; van Kleef ESB; Koene S; Smeitink JAM; Küsters B; van Tienen FHJ; Smeets HJM; van Engelen BGM; Erasmus CE; Voermans NC
BMC Neurol; 2021 Aug; 21(1):313. PubMed ID: 34384384
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of laminin beta 1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy.
Li M; Dickson DW; Spiro AJ
Arch Neurol; 1997 Dec; 54(12):1457-61. PubMed ID: 9400354
[TBL] [Abstract][Full Text] [Related]
17. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy.
Talim B; Kale G; Topaloglu H; Akçören Z; Caglar M; Gögüş S; Elkay M
Pediatr Dev Pathol; 2000; 3(2):168-76. PubMed ID: 10679036
[TBL] [Abstract][Full Text] [Related]
20. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42.
Brockington M; Sewry CA; Herrmann R; Naom I; Dearlove A; Rhodes M; Topaloglu H; Dubowitz V; Voit T; Muntoni F
Am J Hum Genet; 2000 Feb; 66(2):428-35. PubMed ID: 10677302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
